Hemochromatosis and Iron Overload Screening (HEIRS) Study Design for an Evaluation of 100,000 Primary Care-Based Adults

The American Journal of the Medical Sciences - Tập 325 Số 2 - Trang 53-62 - 2003
Christine E. McLaren1, James C. Barton2, Paul C. Adams3, Emily Harris4, Ronald T. Acton5, Nancy Press6, David M. Reboussin7, Gordon D. McLaren8,9, Phyliss Sholinsky10, Ann P. Walker1, Victor R. Gordeuk11, Catherine Leiendecker–Foster12, Fitzroy W. Dawkins11, John H. Eckfeldt13, Beverly G. Mellen7, Mark Speechley3, Elizabeth J. Thomson10
1University of California, at Irvine#TAB#
2Southern Iron Disorders Center
3Western University
4Kaiser Permanente
5University of Alabama
6Oregon Health and Science University
7Wake Forest University
8University of California at Irvine
9VA Medical Center
10NATIONAL INSTITUTES OF HEALTH
11Howard University
12University of Minnesota Twin Cities
13Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adams, 1995, Screening blood donors for hereditary hemochromatosis: decision and analysis model based on a 30-year database, Gastroenterology, 109, 177, 10.1016/0016-5085(95)90283-X

Witte, 1996, Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis, Clin Chim Acta, 245, 139, 10.1016/0009-8981(95)06212-2

Gordeuk, 1994, Etiologies, consequences and treatment of iron overload, Crit Rev Clin Lab Sci, 31, 89, 10.3109/10408369409084674

Barton, 1998, Management of hemochromatosis, Ann Intern Med, 129, 932, 10.7326/0003-4819-129-11_Part_2-199812011-00003

Adams, 1991, Long-term survival analysis in hereditary hemochromatosis, Gastroenterology, 101, 368, 10.1016/0016-5085(91)90013-B

Niederau, 1996, Long-term survival in patients with hereditary hemochromatosis, Gastroenterology, 110, 1107, 10.1053/gast.1996.v110.pm8613000

Barton, 1995, Iron overload in African Americans, Am J Med, 99, 616, 10.1016/S0002-9343(99)80248-4

Wurapa, 1996, Primary iron overload in African Americans, Am J Med, 101, 9, 10.1016/S0002-9343(96)00053-8

Phatak, 1998, Prevalence of hereditary hemochromatosis in 16,031 primary care patients, Ann Intern Med, 341, 725

Roetto, 1999, Juvenile hemochromatosis locus maps to chromosome 1q, Am J Hum Genet, 64, 1388, 10.1086/302379

Beutler, 2000, The effect ofHFEgenotypes on measurements of iron overload in patients attending a health appraisal clinic, Ann Intern Med, 133, 329, 10.7326/0003-4819-133-5-200009050-00008

Camaschella, 2000, The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22, Nat Genet, 25, 14, 10.1038/75534

Montosi, 2001, Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene, J Clin Invest, 108, 619, 10.1172/JCI200113468

Feder, 1996, A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis, Nat Genet, 13, 399, 10.1038/ng0896-399

Burke, 1998, Hereditary hemochromatosis: gene discovery and its implications for population-based screening, JAMA, 280, 172, 10.1001/jama.280.2.172

Steinberg, 2001, Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States, JAMA, 285, 2216, 10.1001/jama.285.17.2216

Lucotte, 2000, Celtic origin of the C282Y mutation of hemochromatosis, Genet Test, 4, 163, 10.1089/10906570050114876

Cullen, 1998, The hemochromatosis 845 G→A and 187 C→G mutations: prevalence in non-Caucasian populations, Am J Hum Genet, 62, 1403, 10.1086/301878

Mortimore, 1999, The haemochromatosis gene: a global perspective and implications for the Asia-Pacific region, J Gastroenterol Hepatol, 14, 838, 10.1046/j.1440-1746.1999.01980.x

Steiner, 2002, A homozygous HFE gene splice site mutation (IVS5+1 G/A) in a hereditary hemochromatosis patient of Vietnamese origin, Gastroenterology, 122, 789, 10.1053/gast.2002.31884

Burke, 2000, Contribution of differentHFEgenotypes to iron overload disease: a pooled analysis, Genet Med, 2, 271, 10.1097/00125817-200009000-00001

Cogswell, 1998, Iron overload, public health, and genetics: evaluation the evidence for hemochromatosis screening, Ann Intern Med, 129, 971, 10.7326/0003-4819-129-11_Part_2-199812011-00008

Adams, 2000, EASL International Consensus Conference on Haemochromatosis, J Hepatol, 33, 485, 10.1016/S0168-8278(01)80874-6

McCullen, 2002, Screening for hemochromatosis, Clin Chim Acta, 315, 169, 10.1016/S0009-8981(01)00711-2

2001

Powell, 1994, Primary iron overload, 247

Edwards, 1988, Prevalence of hemochromatosis among 11, 065 presumably healthy blood donors, N Engl J Med, 318, 1355, 10.1056/NEJM198805263182103

McDonnell, 1998, Screening for hemochromatosis in primary care settings, Ann Intern Med, 129, 962, 10.7326/0003-4819-129-11_Part_2-199812011-00007

1994

Adams, 1998, Factors affecting the rate of iron mobilization during venesection therapy for genetic hemochromatosis, Am J Hematol, 59, 16, 10.1002/(SICI)1096-8652(199805)58:1<16::AID-AJH3>3.0.CO;2-3

Barton, 2001, Inheritance of twoHFEmutations in African Americans: cases with hemochromatosis phenotypes and estimates of hemochromatosis phenotype frequency, Genet Med, 3, 294, 10.1097/00125817-200107000-00005

Gordeuk, 1998, Distribution of transferrin saturations in the African-American population, Blood, 91, 2175, 10.1182/blood.V91.6.2175

McLaren, 2001, Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey, Blood, 98, 2345, 10.1182/blood.V98.8.2345

Gordeuk, 1992, Iron overload in Africa. Interaction between a gene and dietary iron content, N Engl J Med, 326, 95, 10.1056/NEJM199201093260204

Marshall, 1999, Prevalence of the C282Y and H63D polymorphisms in a multi-ethnic control population, Int J Mol Med, 4, 389

Djousse, 1988, Relation between dietary fiber consumption and fibrinogen and plasminogen activator inhibitor type 1: The National Heart, Lung, and Blood Institute Family Heart Study, Am J Clin Nutr, 68, 568, 10.1093/ajcn/68.3.568

Beutler, 2002, Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA, Lancet, 359, 211, 10.1016/S0140-6736(02)07447-0

Cook, 2000, Hemochromatosis: effect of iron fortification of foods, 535

Bell, 2000, The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even inHFEC282Y mutation negative subjects, Scand J Gastroenterol, 35, 1301, 10.1080/003655200453665

Brittenham, 1998, Research priorities in hereditary hemochromatosis, Ann Intern Med, 129, 993, 10.7326/0003-4819-129-11_Part_2-199812011-00011